Start-up offers new power route for artificial heart

Article Abstract:

World Heart Corp. offers a new power route for artificial hearts. The Canadian start-up expects to earn US$13 million in its first year of sales in the year 2001. World Heart's product, the HeartSaver, is gaining attention, because of the way it is powered and its compact size. Instead of using an external power source that uses wires, the left-ventricular-assist device is powered by a system that uses electromagnetism. A small battery is taped to the chest, and energy is transmitted through the skin to an adjacent coil implanted in the body.

Comment:

World Heart Corp. offers new power route for artificial heart

Canada, Product information, Medical Instruments & Equipment, Medical Equipment and Supplies Manufacturing, Medical equipment, World Heart Corp., Article

---

FDA clears Chiron's hepatitis C virus test that is more accurate

Article Abstract:

Considered more sensitive and consequently more reliable, a new blood test from Chiron Corp. of Emeryville, Calif., verifies that a liver transplant is likely needed. New Jersey-based Ortho Diagnostic Systems Inc. will distribute the product, RIBA HCV 3.0 Strip Immunoblot Assay, to medical facilities. The new test will preclude the need to notify thousands of people who are not at risk of getting hepatitis C.

Comment:

New test fine-tunes number of people at risk

United States, Research and Development in the Physical, Engineering, and Life Sciences, Marketing procedures, Chemistry, Marketing, Testing, Abstract, Hepatitis C, Blood, Chiron Corp., CHIR, Blood chemical analysis

---

Similar abstracts:

• Abstracts: Sport: the new media power. Trouble in the drug trade. Relative values: listed family companies markedly outperform the All Ordinaries index
• Abstracts: The new corporate watchdog ponders how to do more with less. Unsecured 'back doors' leave companies open to hacker attack
• Abstracts: Northrop set to cut jobs, restructure. FAA to require Boeing jets to be inspected Boeing Co. to phase out production of MD-11 aircraft over next 20 months
• Abstracts: Johnson & Johnson drug may pose risks. Northeast Utilities is cleared to start unit at Millstone
• Abstracts: Beijing orders brokerage firms Guotai Securities, J&A to merge

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.